InBioGen Co (101140.KS) Stock Price
InBioGen Co Price
Revenue at InBioGen Co has contracted by 6.8% per year over the past 17 years to 6.30 B KRW. Earnings per share have grown at 4.2% per year over the last 15 years. For InBioGen Co, the net margin of -22.5% is down versus 898.1% a few years ago.
InBioGen Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
InBioGen Co business model & stock analysis
Frequently asked questions about InBioGen Co
Converted at the current exchange rate, the InBioGen Co share trades at 3.32 EUR (4,960.00 KRW).
The revenue cannot currently be calculated for InBioGen Co.
The profit cannot currently be calculated for InBioGen Co.
The P/E ratio cannot be calculated for InBioGen Co at the moment.
The P/S cannot be calculated for InBioGen Co currently.
The Eulerpool Quality Score for InBioGen Co is 1/10.
The ISIN of InBioGen Co is KR7101140002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of InBioGen Co is 101140.KS. The ticker symbol is used to trade InBioGen Co shares on the stock exchange.
InBioGen Co stock
InBioGen Co Peer Group
InBioGen Co FIGI
All fundamentals and in-depth analysis of InBioGen Co
Our stock analysis for InBioGen Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InBioGen Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.